Effects of Acupuncture in lumbar spinal canal stenosis ; Effects of Mesotherapy with calcitonin in lumbar spinal canal stenosis

Evaluating effects of Acupuncture versus Mesotherapy with Calcitonin in Patients with Lumbar Spinal Canal stenosis( randomized controlled clinical trial)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250511065690N1

Enrollment

Registered

2025-06-12

Start date

2025-08-23

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LUMBAR SPINAL CANAL STENOSIS. Spinal stenosis, lumbar region

Interventions

Intervention 1: Intervention group: A)mesotherapy with calcitonine and exercises in the form of three injection sessions (two 50-unit ampoules of calcitonin + 4 cc of 2% lidocaine per session) with

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 40-75 years old confirmation of the diagnosis of lumbar spinal canal stenosis by radiography, MRI, or Electrodiagnosis study. ATleast 6 months should have passed since the onset of symptoms of lumbar spinal canal stenosis ( such as low back pain, claudication, radicular leg pain, etc.)

Exclusion criteria

Exclusion criteria: pregnancy breastfeeding critical systemic or local infection uncontrolled diabetes Rheumatic and collagen vascular diseases cancer history of severe hepatic, renal, cardiac, or pulmonary disease bleeding disorders use of anticoagulants Brucellosis history of spinal canal surgery Diabetic neuropathy Concurrent radiculopathy BMI over 42 history of allergic reaction to the drug used in the study presence of cauda equina syndrome symptoms(perineal numbness, urinary and fecal incontinence) muscle weakness with manual muscle test score less than 4 out of 5 inability to communicate and complete the questionnaire history of acupuncture or calcitonin injection in thepast three months

Design outcomes

Primary

Measure	Time frame
Pain Intensity. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: VAS(Visual)analoge scale.;Function. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: health Shortform_(survey(SF_36 Quebec scale(QBPDS disability pain(back.;Ability to hop on one leg for 5 steps. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: hopping standard scale (SHS ).	—

Measure

Time frame

Pain Intensity. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: VAS(Visual)analoge scale.;Function. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: health Shortform_(survey(SF_36 Quebec scale(QBPDS disability pain(back.;Ability to hop on one leg for 5 steps. Timepoint: Before treatment, 4 and 8 weeks after start treatment. Method of measurement: hopping standard scale (SHS ).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Rashidirezvan

Shiraz University of Medical Sciences

Nazaninrashidi4872@gmail.com009871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026